|
Volumn 244, Issue 2, 2007, Pages 323-324
|
Science to practice: Does MR imaging improve precision in stroke thrombolysis trials?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FIBRINOLYTIC AGENT;
TISSUE PLASMINOGEN ACTIVATOR;
MICROPLASMIN;
PEPTIDE FRAGMENT;
PLASMIN;
UNCLASSIFIED DRUG;
BRAIN BLOOD VOLUME;
BRAIN INFARCTION SIZE;
BRAIN PERFUSION;
COMPUTER ASSISTED TOMOGRAPHY;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC IMAGING;
DISEASE COURSE;
DISEASE MODEL;
FIBRINOLYTIC THERAPY;
HUMAN;
IMAGE ANALYSIS;
IMAGING SYSTEM;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATIENT SELECTION;
PREDICTION;
PRIORITY JOURNAL;
SHORT SURVEY;
STROKE;
TREATMENT PLANNING;
ANIMAL;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
INTRAARTERIAL DRUG ADMINISTRATION;
METHODOLOGY;
NOTE;
PATHOLOGY;
RAT;
ANIMALS;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIALS;
FIBRINOLYTIC AGENTS;
INJECTIONS, INTRA-ARTERIAL;
MAGNETIC RESONANCE IMAGING;
PEPTIDE FRAGMENTS;
PLASMIN;
RATS;
THROMBOLYTIC THERAPY;
TISSUE PLASMINOGEN ACTIVATOR;
|
EID: 34447509713
PISSN: 00338419
EISSN: None
Source Type: Journal
DOI: 10.1148/radiol.2442062193 Document Type: Short Survey |
Times cited : (3)
|
References (5)
|